UNE’s Ed Li presents drug expenditure research at national oncology conference

Edward Li, Pharm.D., M.P.H., BCOP, professor in the College of Pharmacy, was selected to discuss his research on cancer-fighting drugs at the annual American Society of Clinical Oncology (ASCO) meeting, held June 2-6, 2017 in Chicago.

Li presented his research on antineoplastic agent expenditures, and the increase in costs of these drugs over the past five years. Li found that antineoplastic expenditures increased significantly since 2011 and are expected to continue to do so. This is a result of the anticipated approval of additional novel but costly cancer therapies, and because of an aging population.

The ASCO Annual Meeting brings together more than 30,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies and ongoing controversies in the world. Research abstracts are selected by the scientific program committee.

To learn more about the University of New England’s College of Pharmacy, visit www.une.edu/pharmacy

To apply, visit www.une.edu/admissions